Evidence map›Paper›PMID 27140650›Full record

ArticlePloS one2016

Advanced Glycation Endproducts and Bone Material Properties in Type 1 Diabetic Mice.

Mishaela R Rubin, Eleftherios P Paschalis, Atharva Poundarik, Gyna E Sroga, Donald J McMahon, Sonja Gamsjaeger, Klaus Klaushofer, Deepak Vashishth

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Advanced-Glycation Endproducts: How cross-linking properties affect the collagen fibril behavior.Journal of the mechanical behavior of biomedical materials · 2023
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. The influence of AGEs and enzymatic cross-links on the mechanical properties of collagen fibrils.Journal of the mechanical behavior of biomedical materials · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Mishaela R RubinDepartment of Medicine, Metabolic Bone Diseases Unit, College of Physicians & Surgeons Columbia University, New York, NY, United States of America.
Eleftherios P PaschalisLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK, and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Atharva PoundarikCenter for Biotechnology & Interdisciplinary Studies, Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, United States of America.
Gyna E SrogaCenter for Biotechnology & Interdisciplinary Studies, Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, United States of America.
Donald J McMahonDepartment of Medicine, Metabolic Bone Diseases Unit, College of Physicians & Surgeons Columbia University, New York, NY, United States of America.
Sonja GamsjaegerLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK, and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Klaus KlaushoferLudwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK, and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria.
Deepak VashishthCenter for Biotechnology & Interdisciplinary Studies, Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Troy, NY, United States of America.

Funding

Effects of Osteocalcin and Osteopontin on Damage Morphology and Bone FragilityR01AR049635 · NIAMS · RENSSELAER POLYTECHNIC INSTITUTE · PI VASHISHTH, DEEPAK · 2002 to 2014
$3.3M
Collagen Crosslinking Effects on Bone FragilityR01AG020618 · NIA · RENSSELAER POLYTECHNIC INSTITUTE · PI VASHISHTH, DEEPAK · 2005 to 2009
$1.1M
Effects of non-enzymatic glycation and collagen crosslinks on bone fragilityR56AG020618 · NIA · RENSSELAER POLYTECHNIC INSTITUTE · PI VASHISHTH, DEEPAK · 2017 to 2017
$386k
NIAMS NIH HHS R01 AR049635NIA NIH HHS R01 AG020618NIA NIH HHS R56 AG020618
6 · The paper itself

Abstract

Fractures, particularly at the lower extremities and hip, are a complication of diabetes. In both type 1 (T1D) and type 2 diabetes (T2D), fracture risk is disproportionately worse than that predicted from the measurement of bone mineral density. Although an explanation for this discrepancy is the presence of organic matrix abnormalities, it has not been fully elucidated how advanced glycation endproducts (AGEs) relate to bone deterioration at both the macroscopic and microscopic levels. We hypothesized that there would be a relationship between skeletal AGE levels (determined by Raman microspectroscopy at specific anatomical locations) and bone macroscopic and microscopic properties, as demonstrated by the biomechanical measures of crack growth and microindentation respectively. We found that in OVE26 mice, a transgenic model of severe early onset T1D, AGEs were increased by Raman (carboxymethyl-lysine [CML] wildtype (WT): 0.0143 ±0.0005 vs T1D: 0.0175 ±0.0002, p = 0.003) at the periosteal surface. These differences were associated with less tough bone in T1D by fracture mechanics (propagation toughness WT: 4.73 ± 0.32 vs T1D: 3.39 ± 0.24 NM/m1/2, p = 0.010) and by reference point indentation (indentation distance increase WT: 6.85 ± 0.44 vs T1D: 9.04 ± 0.77 μm; p = 0.043). Within T1D, higher AGEs by Raman correlated inversely with macroscopic bone toughness. These data add to the existing body of knowledge regarding AGEs and the relationship between skeletal AGEs with biomechanical indices.

Indexed as

Mechanical PhenomenaAnimalsBiomechanical PhenomenaBone and BonesBone DensityDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1FemaleFractures, BoneGlycation End Products, AdvancedMiceGlycation End Products, Advanced

Identifiers

PMID27140650
PMCPMC4854398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.